Monitoring GLP-1 Drugs and Vision Risks Documented Cases: In relation to GLP-1 medications and vision-related issues, the FDA has received several reports documenting cases of NAION in individuals using semaglutide and tirzepatide products
A molecule that size does not simply diffuse across an intact barrier, which is exactly why real GLP-1 medications are injected or specially formulated to survive digestion rather than pressed on as an adhesive sticker
Little work has previously been undertaken to evaluate safety with long-term efficacy and cardio-renal benefits of such therapies
Discover more about our team of specialists.
At the same time, your body may alter thyroid hormone metabolism, slow down movement (often subconscious), and even shift gut microbiome composition to favor calorie extraction from food
Consider side effect profiles : Discuss tolerance for gastrointestinal symptoms versus risk of genitourinary infections